The novel pharmacoenhancer cobicistat boosts blood levels of atazanavir as well as ritonavir and is generally safe and well-tolerated over 48 weeks, according to final study results published in the July 1, 2013, Journal of Infectious Diseases .
http://www.hivandhepatitis.com/hiv-treatment/experimental-hiv-drugs/4121-cobicistat-booster-is-a-safe-and-effective-alternative-to-ritonavir
http://www.hivandhepatitis.com/hiv-treatment/experimental-hiv-drugs/4121-cobicistat-booster-is-a-safe-and-effective-alternative-to-ritonavir
No comments:
Post a Comment